NBIX Sale Disclosure
Boyer David W. · SEC Form 4 · Filed Sep 15, 2026
Sale
Calculated transaction value
$130.05K
Boyer David W. Chief Corp. Affairs Officer
NBIX
Transaction date
Sep 14, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed 1 day later
NBIX daily price context
Close on/before transaction
$157.22
Sep 14, 2026
Close before public filing
$157.22
Sep 14, 2026
Return since public filing
-3.91%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 826 shares @ $157.45
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001909817-26-000010
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$432.49K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX Current | Sale | Sep 14, 2026 | $130.05K |
| Neurocrine Biosciences Inc NBIX | Award | Sep 11, 2026 | $0 |
| Neurocrine Biosciences Inc NBIX | Disposition | Sep 11, 2026 | $302.44K |